STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

PacBio to Report Fourth Quarter 2024 Financial Results on February 13, 2025

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

PacBio (PACB) has scheduled its fourth quarter 2024 financial results conference call for Thursday, February 13, 2025, at 4:30 pm Eastern Time (1:30 pm Pacific Time). Investors and interested parties can access the webcast through PacBio's investor relations website. For those preferring to dial in, toll-free and international numbers are available, and participants are advised to join ten minutes before the start time.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

MENLO PARK, Calif., Jan. 30, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its fourth quarter 2024 financial results on Thursday, February 13, 2025, at 4:30 pm Eastern Time.

The call will be webcast and may be accessed at PacBio’s website at https://investor.pacificbiosciences.com/.

Date: Thursday, February 13, 2025, at 4:30 pm ET (1:30 pm PT)
Listen live via internet or replay: https://investor.pacificbiosciences.com/
Toll-free: 1-888-349-0136
International: 1-412-317-0459

If using the dial-in option, please join the call ten minutes before the start time using the appropriate number above and ask to join the “PacBio Q4 Earnings Call.”

About PacBio

Pacific Biosciences of California, Inc. (NASDAQ: PACB) is a premier life science technology company that designs, develops, and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. Our products and technologies stem from two highly differentiated core technologies focused on accuracy, quality, and completeness, which include our HiFi long-read sequencing and our SBB® short-read sequencing technologies. Our products address solutions across a broad set of research applications, including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. For more information, please visit www.pacb.com and follow @PacBio.

PacBio products are provided for Research Use Only. Not for use in diagnostic procedures.

Contacts

Investors:
Todd Friedman
ir@pacb.com

Media:
pr@pacb.com


FAQ

When will PacBio (PACB) report Q4 2024 earnings?

PacBio will report its Q4 2024 earnings on Thursday, February 13, 2025, at 4:30 pm Eastern Time (1:30 pm Pacific Time).

How can investors access PacBio's (PACB) Q4 2024 earnings call?

Investors can access the earnings call through PacBio's investor relations website at https://investor.pacificbiosciences.com/ or by dialing 1-888-349-0136 (toll-free) or 1-412-317-0459 (international).

What time should participants join PacBio's (PACB) Q4 2024 earnings call?

Participants using the dial-in option should join the call ten minutes before the start time at 4:30 pm ET.

Will there be a replay available for PacBio's (PACB) Q4 2024 earnings call?

Yes, a replay of the earnings call will be available through PacBio's investor relations website at https://investor.pacificbiosciences.com/.
Pacific Biosc

NASDAQ:PACB

PACB Rankings

PACB Latest News

PACB Latest SEC Filings

PACB Stock Data

670.23M
274.44M
9.05%
56.36%
12.36%
Medical Devices
Laboratory Analytical Instruments
Link
United States
MENLO PARK